mutation: lead to cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents variation
Weight: 0.58
, event
Weight: 0.57
, factor
Weight: 0.53
, thing
Weight: 0.53
, concept
Weight: 0.51
Siblings polymorphism
Weight: 0.54
, translocation
Weight: 0.45
, gene
Weight: 0.34
, genotype
Weight: 0.33
, atherosclerosis
Weight: 0.32

Related properties

Property Similarity
lead to cancer 1.00
lead to skin cancer 0.94
be in p53 lead to cancers 0.90
cause cancer 0.88
be related to cancer development 0.82
cause disease 0.76
lead to new species 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.59
Similarity weight: 0.76
Evidence: 0.60
¬ Remarkable(mutation, lead to cancer)
Evidence: 0.69
¬ Remarkable(gene, cause disease)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.69
Remarkable(gene, cause disease)
Evidence: 0.59
¬ Plausible(gene, cause disease)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.91
¬ Salient(mutation, lead to cancer)

Similarity expansion

0.75
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.94
Evidence: 0.93
Typical(mutation, lead to cancer)
Evidence: 0.97
¬ Typical(mutation, lead to skin cancer)
0.73
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.91
Salient(mutation, lead to cancer)
Evidence: 0.95
¬ Salient(mutation, lead to skin cancer)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.94
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.92
¬ Plausible(mutation, lead to skin cancer)
0.71
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.88
Evidence: 0.93
Typical(mutation, lead to cancer)
Evidence: 0.75
¬ Typical(mutation, cause cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.88
Evidence: 0.91
Salient(mutation, lead to cancer)
Evidence: 0.71
¬ Salient(mutation, cause cancer)
0.69
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.88
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.68
¬ Plausible(mutation, cause cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.93
Typical(mutation, lead to cancer)
Evidence: 0.84
¬ Typical(mutation, be related to cancer development)
0.64
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.82
Evidence: 0.91
Salient(mutation, lead to cancer)
Evidence: 0.93
¬ Salient(mutation, be related to cancer development)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.93
Typical(mutation, lead to cancer)
Evidence: 0.15
¬ Typical(mutation, cause disease)
0.63
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.82
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.84
¬ Plausible(mutation, be related to cancer development)
0.62
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.30
¬ Plausible(mutation, cause disease)
0.62
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.91
Salient(mutation, lead to cancer)
Evidence: 0.43
¬ Salient(mutation, cause disease)
0.61
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.94
Evidence: 0.60
Remarkable(mutation, lead to cancer)
Evidence: 0.60
¬ Remarkable(mutation, lead to skin cancer)
0.58
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.88
Evidence: 0.60
Remarkable(mutation, lead to cancer)
Evidence: 0.57
¬ Remarkable(mutation, cause cancer)
0.48
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.82
Evidence: 0.60
Remarkable(mutation, lead to cancer)
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
0.42
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.76
Evidence: 0.60
Remarkable(mutation, lead to cancer)
Evidence: 0.86
¬ Remarkable(mutation, cause disease)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.91
Salient(mutation, lead to cancer)
Evidence: 0.93
¬ Typical(mutation, lead to cancer)
Evidence: 0.60
¬ Remarkable(mutation, lead to cancer)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.88
Plausible(mutation, lead to cancer)
Evidence: 0.93
¬ Typical(mutation, lead to cancer)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.60
¬ Remarkable(mutation, lead to cancer)
Evidence: 0.61
¬ Typical(gene, cause disease)